“Improved supply chains and demand forecasting is essential to ensure that life saving drugs reach patients in need. The new Artemisinin-based combination therapies (ACTs) provide a unique opportunity to tackle unacceptable burden of malaria. In order to manage risks and opportunities, manufacturers, procurement agencies and donors need clarity in the medium term … Read more